Posted On: 11/07/2015 9:19:26 AM
Post# of 30066
Analysts Opinion - Amarantus Bioscience Holdings $AMBS
Price Target Summary:
Mean Target: 31.67
Median Target: 31.67
High Target: 45.34
Low Target: 18.00
No. of Brokers: 2
https://finance.yahoo.com/q/ao?s=AMBS
November 5, 2015 - SeeThruEquity Issues Update on Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) Highlighting Partnership with U.S. Army and Orphan Drug Application for Eltoprazine
Price target: $45.34 per share.
https://finance.yahoo.com/news/seethruequity-...00097.html
Price Target Summary:
Mean Target: 31.67
Median Target: 31.67
High Target: 45.34
Low Target: 18.00
No. of Brokers: 2
https://finance.yahoo.com/q/ao?s=AMBS
November 5, 2015 - SeeThruEquity Issues Update on Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) Highlighting Partnership with U.S. Army and Orphan Drug Application for Eltoprazine
Price target: $45.34 per share.
https://finance.yahoo.com/news/seethruequity-...00097.html
(0)
(0)
